Johnson & Johnson earnings: Time to talk about drug prices
July 16, 2018 at 14:18 PM EDT
The drug pricing controversy isn’t going away anytime soon, hardly good news for pharmaceutical companies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|